THRIVE has begun screening infants aged 6 to 12 months to evaluate whether early treatment with the VIASKIN Peanut Patch can alter peanut allergy.
Douglas Mack, MD, MSc, FRCPC
Advertisement
Douglas Mack, MD, MSc, FRCPC, pediatric allergist and assistant clinical professor at McMaster University.
Articles by Douglas Mack, MD, MSc, FRCPC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: Which children with early puberty actually need testing and treatment?
2
Researchers identify hypermobility-linked autonomic subtype of eosinophilic esophagitis in children
3
Preventing constipation, dehydration, and snack chaos during summer travel
4
Prenatal acid-suppressive medication exposure shows no consistent link to pediatric inflammatory bowel disease
5